These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2759966)

  • 21. Mechanisms of hypotension produced by platelet-activating factor.
    Laurindo FR; Goldstein RE; Davenport NJ; Ezra D; Feuerstein GZ
    J Appl Physiol (1985); 1989 Jun; 66(6):2681-90. PubMed ID: 2745330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat.
    Bellan JA; Minkes RK; Hood JS; McMahon TJ; Higuera TR; Nossaman BD; McNamara DB; Kadowitz PJ
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H234-43. PubMed ID: 1379004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs.
    Armstead WM; Pourcyrous M; Mirro R; Leffler CW; Busija DW
    Circ Res; 1988 Jan; 62(1):1-7. PubMed ID: 3335052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of SQ 29,548 on vasoconstrictor responses in the hindquarters vascular bed of the cat.
    Minkes RK; Bellan JA; McMahon TJ; McNamara DB; Kadowitz PJ
    Prostaglandins Leukot Essent Fatty Acids; 1991 Oct; 44(2):83-8. PubMed ID: 1836063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of PAF-induced death in mice.
    Myers AK; Nakanishi T; Ramwell P
    Prostaglandins; 1988 Mar; 35(3):447-58. PubMed ID: 3131837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig.
    Lötvall J; Elwood W; Tokuyama K; Sakamoto T; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1992 Jun; 72(6):2415-9. PubMed ID: 1385805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of thromboxane/endoperoxide receptor-mediated responses in the pulmonary vascular bed of the cat by sulotroban.
    Nossaman BD; McMahon TJ; Ragheb MS; Ibrahim IN; Babycos CR; Hood JS; Kadowitz PJ
    Eur J Pharmacol; 1992 Mar; 213(1):1-7. PubMed ID: 1379928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane receptor antagonist properties of SQ 27,427 in the anesthetized guinea pig.
    Greenberg R; Steinbacher TE; Harris DN; Haslanger MF
    Eur J Pharmacol; 1984 Aug; 103(1-2):19-24. PubMed ID: 6090175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin.
    Uhlig S; Nüsing R; von Bethmann A; Featherstone RL; Klein T; Brasch F; Müller KM; Ullrich V; Wendel A
    Mol Med; 1996 May; 2(3):373-83. PubMed ID: 8784790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of thromboxane responses in the airway of the cat by SQ29,548 and OKY 1581.
    Kadowitz PJ; McNamara DB; Tilden SJ; Hyman AL; Underwood DC
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():535-8. PubMed ID: 2526533
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane effects on canine trachealis neuromuscular function.
    Serio R; Daniel EE
    J Appl Physiol (1985); 1988 May; 64(5):1979-88. PubMed ID: 2839451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
    Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of airway contractile responses within the major diameter bronchi during exogenous bronchoconstriction.
    Shioya T; Solway J; Munoz NM; Mack M; Leff AR
    Am Rev Respir Dis; 1987 May; 135(5):1105-11. PubMed ID: 3555187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.
    Esplugues JV; Whittle BJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G275-82. PubMed ID: 2919672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal pulmonary vasodilation after exogenous platelet-activating factor.
    Accurso FJ; Abman SH; Wilkening RB; Worthen GS; Henson P
    J Appl Physiol (1985); 1991 Feb; 70(2):778-87. PubMed ID: 2022570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of platelet-activating factor on rat airways.
    Misawa M; Takata T
    Jpn J Pharmacol; 1988 Sep; 48(1):7-13. PubMed ID: 3199608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SK&F 88046: inhibition of thromboxane-induced bronchoconstriction in anesthetized dogs.
    Wasserman MA; Malo PE
    Prostaglandins Leukot Med; 1985 Feb; 17(2):213-22. PubMed ID: 2858866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.